2 research outputs found
Clinical Uses and Differences Among the Selective Serotonin Reuptake Inhibitors
- Author
- Adly C
- Alderman C P
- Andersen G
- Balon R
- Barbey J T
- Barrickman L
- Baumann P
- Cada D J
- Celexa
- Chouinard G
- Diamond S
- Evans D L
- FDA approves Zoloft for posttraumatic stress disorder
- Findling R L
- Frederick W. Reimherr
- Frye C B
- GenRx Mosby's
- Gillin J C
- Goodman W K
- Gorman J M
- Hansten P D
- Harten J V
- Jonathon W. Raap
- Kam P CA
- Kissner M
- Labellarte M J
- Lacy C F
- Lemberger L
- Liebowitz M R
- Luvox
- M. Christina Beckwith
- Mayer L ES
- Nurnberg H G
- Nyth A L
- Paxil
- Prozac
- Rosen R C
- Settle E C
- Sharpley A L
- Sheehan D V
- Sporer K A
- Stark P
- Steiner M
- Tilhonen J
- Wilde M I
- Woodrum S T
- Zoloft
- Publication venue
- 'The Haworth Press'
- Publication date
- Field of study
No full textSpecial Population Studies In Clinical Development: Pharmacokinetic Considerations
- Author
- A Rane
- ADM Kashuba
- AJ McLean
- AJJ Wood
- American Academy of Pediatrics Committee on Drugs
- American Academy of Pediatrics Committee on Drugs
- American Academy of Pediatrics Committee on Drugs
- Anonymous
- AR Scialli
- BF Tregaskis
- C Bergquist
- CC Lee
- Cefzil
- Cipro
- CP Milne
- CS Lee
- CW Howden
- CX Xie
- DA Spyker
- DB Webb
- DJ Back
- DJ Belle
- DJ Morgan
- DW Cockcroft
- E Autret
- E Keller
- E Singlas
- E Tanaka
- European Commission Enterprise Directorate-General
- European Commission Enterprise Directorate-General
- Exelon
- Food and Drug Administration
- Food and Drug Administration
- Food and Drug Administration
- Food and Drug Administration
- Food and Drug Administration
- Food and Drug Administration
- Food and Drug Administration
- Food and Drug Administration
- Food and Drug Administration
- Food and Drug Administration
- Food and Drug Administration
- Food and Drug Administration
- Food and Drug Administration
- Food and Drug Administration
- Food and Drug Administration
- Food and Drug Administration and the National Institutes of Health Conference
- Food and Drug Administration. Qualifying for pediatric exclusivity under section 505A of the Federal Food
- G Levy
- G Maletta
- GJ Schwartz
- GJ Schwartz
- GL Kearns
- GL Kearns
- GL Kearns
- H Shirkey
- HG Xie
- HP Freeman
- I Beierle
- International Committee on Harmonization
- International Conference on Harmonization
- International Conference on Harmonization
- J Boelaert
- J Brockmoller
- J George
- J Marshall
- JA Goldstein
- JA Johnston
- JF Westphal
- JG Gambertoglio
- JK Bush
- JM Kovarik
- JM Kovarik
- JM Kovarik
- JM Kovarik
- JMA Geerven Van
- JS Kim
- JS Leeder
- JT Wilson
- JT Wilson
- KE Zenk
- L Collart
- L Murray
- LE Gustayson
- LJ Lesko
- Luvox
- LZ Benet
- M Rowland
- MC Nahata
- MD Reed
- MD Reed
- ME Kitler
- MJ Reed
- ML Chen
- ML Chen
- MT Kinirons
- MW Foster
- P Crome
- PID Lee
- PL Morselli
- Prilosec
- R Roberts
- RB Merkatz
- RE Kauffman
- RJ Ptachcinski
- RL Breitzka
- RNH Pugh
- RZ Harris
- S Dunn
- S Hartter
- S Ibrahim
- Simulect (basiliximab)
- SJ Pamis
- SN Cohen
- SS Anand
- T Andersson
- T Bergan
- T Furuta
- T McRorie
- TA Sheldon
- V Ozdemir
- V Rodighiero
- V Sekar
- Versed
- WC Shyu
- WD Figg
- Y Caraco
- YWF Lam
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- 01/01/2004
- Field of study
No full text
